Abstract
<h3>Watch the video or read the poster to learn:</h3> <ul><li>How to choose the right transfection reagent</li><li>Impact of transfection performance on viral vector manufacturing costs and costs per dose</li><li>How novel technology can reduce AAV manufacturing costs</li></ul><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsights.blob.core.windows.net/uploads/Dumont headshot copy.png" data-image="1"></div><div class="author-det"> <b>Maxime Dumont</b> is a cell and gene therapy product manager at Polyplus-transfection®. With two master’s degrees in biochemistry, project management and marketing of pharmaceutical products, Maxime is managing the CGT transfection reagent portfolio for over 4 years. </div></div></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
